In February, the National Institutes of Health (NIH), RSNA and American College of Radiology (ACR) cosponsored a workshop about the safety of gadolinium-based contrast agents (GBCAs). Now, they've published a "roadmap" about what researchers know—and don't know—about GBCAs.